| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Pathology (K.A.K., J.M.G.), Orthodontics (K.A.K.), and Surgery (J.M.G.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190; Immunobiology & Cancer (K.A.K., J.M.G.), Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104
Address all correspondence and requests for reprints to: Dr. Jeffrey M. Gimble, Department of Surgery, University of Oklahoma Health Sciences Center, Williams Pavilion 2140, WP2140, 920 Stanton L. Young Boulevard, Oklahoma City, Oklahoma 73190. E-mail: Jeffrey-Gimble{at}ouhsc.edu
Bone marrow stromal stem cells differentiate into adipocytes and osteoblasts. These two lineages are thought to be reciprocally related, in part due to the observation that the osteoblast-inducing factor, 1,25 dihydroxy vitamin D3 [1,25(OH)2D3], inhibited adipogenesis of rat femoral-derived stromal cell cultures. However, the literature is divided concerning the adipogenic effects of this steroid hormone. This work examined the effect of 1,25(OH)2D3 (10-1210-8 M) on murine femoral-derived bone marrow stromal cell differentiation in response to adipogenic agonists employing two different classes of nuclear hormone receptors: the glucocorticoid receptor (hydrocortisone) or peroxisome proliferator-activated receptors (thiazolidinediones). Experiments used the multipotent murine bone marrow stromal cell line, BMS2, and its subclones, as well as primary-derived murine bone marrow stromal cell cultures. In all systems examined, 1,25(OH)2D3 blocked adipogenesis induced by hydrocortisone, methylisobutylxanthine, and indomethacin based on flow cytometric analysis of lipid accumulation. This correlated with reduced messenger RNA levels of the late adipocyte gene markers, aP2 and adipsin. In the BMS2 subclone no. 24, the 1,25(OH)2D3 actions were concentration dependent. Whereas 1,25(OH)2D3 partially inhibited thiazolidinedione-induced adipogenesis in the parental BMS2 cell line, it had minimal effect on the thiazolidinedione-induced differentiation of the BMS2 subclone and primary cultures. These findings indicate that 1,25(OH)2D3, at nanomolar concentrations, completely inhibits murine bone marrow stromal cell differentiation in response to glucocorticoid-based adipogenic agonists but is a less effective adipogenic antagonist following induction with thiazolidinediones. This work supports the conclusion that 1,25(OH)2D3 inhibits murine femoral-derived bone marrow stromal cell adipogenesis.
This article has been cited by other articles:
![]() |
M. J Bolland, P A. Barber, R. N Doughty, B. Mason, A. Horne, R. Ames, G. D Gamble, A. Grey, and I. R Reid Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial BMJ, February 2, 2008; 336(7638): 262 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, M. Chan, and J. E Aubin Pleiotropic effects of the steroid hormone 1,25-dihydroxyvitamin D3 on the recruitment of mesenchymal lineage progenitors in fetal rat calvaria cell populations. J. Mol. Endocrinol., June 1, 2006; 36(3): 425 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kong and Y. C. Li Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E916 - E924. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Blumberg, I. Tzameli, I. Astapova, F. S. Lam, J. S. Flier, and A. N. Hollenberg Complex Role of the Vitamin D Receptor and Its Ligand in Adipogenesis in 3T3-L1 Cells J. Biol. Chem., April 21, 2006; 281(16): 11205 - 11213. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gong, D. Xie, Z. Deng, R. M. Bostick, S. J. Muga, T. G. Hurley, and J. R. Hebert The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas Carcinogenesis, March 1, 2005; 26(3): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, D.-K. Lee, E. Choi, and J. W. Lee Identification of a Functional Vitamin D Response Element in the Murine Insig-2 Promoter and Its Potential Role in the Differentiation of 3T3-L1 Preadipocytes Mol. Endocrinol., February 1, 2005; 19(2): 399 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peister, J. A. Mellad, B. L. Larson, B. M. Hall, L. F. Gibson, and D. J. Prockop Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential Blood, March 1, 2004; 103(5): 1662 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sekiya, B. L. Larson, J. R. Smith, R. Pochampally, J.-G. Cui, and D. J. Prockop Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality Stem Cells, November 1, 2002; 20(6): 530 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Minguell, A. Erices, and P. Conget Mesenchymal Stem Cells Experimental Biology and Medicine, June 1, 2001; 226(6): 507 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Okazaki, M. Toriumi, S. Fukumoto, M. Miyamoto, T. Fujita, K. Tanaka, and Y. Takeuchi Thiazolidinediones Inhibit Osteoclast-Like Cell Formation and Bone Resorption in Vitro Endocrinology, November 1, 1999; 140(11): 5060 - 5065. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |